Surgical tretment augumented by autologous platelet-rich plasma for osteonecrosis or nonunion in the orthopaedic field

Surgical tretment augumented by autologous platelet-rich plasma for osteonecrosis or nonunion in the orthopaedic field - Surgical tretment augumented by autologous platelet-rich plasma for osteonecrosis or nonunion in the orthopaedic field

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017932

Enrollment

Registered

2015-06-20

Start date

2015-06-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteonecrosis or nonunion in the orthopaedic field

Interventions

Surgical treatment for the osteonecrosis or nonunion in the orthopaedic field is augumented by the administration of autologus PRP(3-5cc)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: In case of osteonecrosis, the patient who diagnosed as osteonecrosis by MRI In case of nonunion, the patient who have had unhealed fracture for more than 3 months The patient who accepts our informed consent

Exclusion criteria

Exclusion criteria: The patient who is pregnant The patient who has allergy for thrombin The patient who has hematologic disease and/or tendency to bleed The patient who shows anemia or thrombocytepenia The patient who can't understand what we ask The patient who can't communicate

Design outcomes

Primary

Measure	Time frame
The percentage of the united bone is detectd by the CT one month after the administration of autologus PRP	—

Countries

Japan

Contacts

Public ContactRikuo Shinomiya

Hiroshima University Hospital Department of orthopaedic surgery

shinomi0123@yahoo.co.jp082-257-5233

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026